XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue:        
Total revenue $ 64,646 $ 74,136 $ 130,951 $ 190,010
Operating expenses:        
Cost of product sales 16,858 21,171 34,158 46,347
Cost of royalty revenue 0 2,493 0 5,072
Research and development 9,833 11,437 19,105 17,545
Selling, general and administrative 27,651 36,832 55,611 59,014
Total operating expenses 54,342 71,933 108,874 127,978
Income from operations 10,304 2,203 22,077 62,032
Interest income 195 244 407 398
Interest expense (1,448) (552) (2,964) (918)
Other income (expense), net 247 (7,763) 9 (9,720)
Total other expense, net (1,006) (8,071) (2,548) (10,240)
Income (loss) before income tax provision 9,298 (5,868) 19,529 51,792
Income tax provision (4,134) (3,582) (8,615) (17,184)
Net income (loss) $ 5,164 $ (9,450) $ 10,914 $ 34,608
Earnings (loss) per share attributable to common stockholders:        
Basic (in dollars per share) $ 0.39 $ (0.74) $ 0.83 $ 2.71
Diluted (in dollars per share) $ 0.39 $ (0.74) $ 0.83 $ 2.67
Weighted average number of common shares outstanding:        
Basic (in shares) 13,090,852 12,836,116 13,075,090 12,773,727
Diluted (in shares) 13,154,599 12,836,116 13,151,107 12,951,788
Product sales, net        
Revenue:        
Total revenue $ 42,993 $ 49,201 $ 89,214 $ 139,289
Royalty revenue        
Revenue:        
Total revenue $ 21,653 $ 24,935 $ 41,737 $ 50,721